Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Alvaro Narrillos-Moraza"'
Autor:
Francisco Tejerina, Cristina Villanueva-Bueno, Alvaro Gimenez-Manzorro, Alejandra Melgarejo-Ortuño, Juan Vicente-Valor, Alvaro Narrillos-Moraza, Ana Herranz, María Olmedo, Beatriz Torroba-Sanz, Silvia Manrique-Rodríguez, Miguel Ángel Amor-García, Esther Chamorro-de-Vega, Emilio Bouza, María Sanjurjo, Maricela Valerio, Vicente Escudero-Vilaplana, Marina Machado, Carmen Guadalupe Rodríguez-González, Patricia Muñoz, Milagros Sancho-Gonzalez
Publikováno v:
International Journal of Antimicrobial Agents
Highlights • Few large series have described the clinical characteristics, treatments, costs and outcomes of COVID-19 patients in western countries. • We report our experience with the first 1,255 cases who received anti-COVID-19 treatment at a S
Autor:
Álvaro Narrillos-Moraza, Patricia Gómez-Martínez-Sagrera, Miguel Ángel Amor-García, Vicente Escudero-Vilaplana, Roberto Collado-Borrell, Cristina Villanueva-Bueno, Ignacio Gómez-Centurión, Ana Herranz-Alonso, María Sanjurjo-Sáez
Publikováno v:
JMIR mHealth and uHealth, Vol 10, Iss 2, p e32826 (2022)
BackgroundHematological conditions are prevalent disorders that are associated with significant comorbidities and have a major impact on patient care. Concerning new tools for the care of these patients, the number of health apps aimed at hematologic
Externí odkaz:
https://doaj.org/article/2da972dc72764be99224d7fddafc2e13